Greater China Funds: China Health Care Reversal
Greater China managers have actively rebalanced portfolios away from China & HK Health Care over the last 6-months, with Taiwan Tech the key...
341 Views
China Healthcare Weekly (Aug.18)- COVID Is Here, BIOSECURE Act Update, Livzon Deserves More Patience
COVID is coming again. So investors can focus on related stocks. US companies leaving Chinese partners due to BIOSECURE Act. Livzon is still worth...
244 Views
Asia Ex-Japan: Extreme Stocks
We screen for stocks at the extreme ends of their positioning or momentum ranges. We combine current and historical data with recent manager...
214 Views
Sai Life Sciences Pre-IPO Tearsheet
SAI Life Sciences(SLS) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and MS.
262 Views
Pre-IPO Elpiscience Biopharmaceuticals - Will Investors Still Buy in These Stories?
Elpiscience's strong capital operation capabilities are no longer enough as investors shift focus to cash flow and drug sales revenue. We have...
248 Views